Oncogene - Table of Contents alert Volume 33 Issue 1

If you are unable to see the message below, click here to view.

Advertisement Current advances in mathematical modeling of anti-cancer drug penetration into tumor tissues  (open access) Delivery of anti-cancer drugs to tumor tissues is a complex process involving various biochemical, mechanical, and biophysical factors. In this review article, Katarzyna A. Rejniak and colleagues present the current state of mathematical modeling approaches that address phenomena related to drug delivery.  Read more high-quality articles from Frontiers in Oncology  TABLE OF CONTENTS Volume 33, Issue 1 (January 2014) In this issue Review Original Articles Short Communication Corrigendum Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement Have you read these most frequently accessed articles from British Journal of Cancer?  Cancer heterogeneity: implications for targeted therapeutics   A nanomaterial-based breath test for distinguishing gastric cancer from benign gastric conditions   Exploiting CTLA-4, PD-1 and PD-L1 to reactivate the host immune response against cancer  Review Top Targeted therapy for melanoma: rational combinatorial approaches L N Kwong and M A Davies Oncogene 2014 33: 1-9; advance online publication, February 18, 2013; 10.1038/onc.2013.34 Abstract | Full Text Original Articles Top Transformation of human ovarian surface epithelial cells by Krüppel-like factor 8 H Lu, X Wang, A M Urvalek, T Li, H Xie, L Yu and J Zhao Oncogene 2014 33: 10-18; advance online publication, December 10, 2012; 10.1038/onc.2012.545 Abstract | Full Text Coordinated regulation of XPA stability by ATR and HERC2 during nucleotide excision repair T-H Lee, J-M Park, S-H Leem and T-H Kang Oncogene 2014 33: 19-25; advance online publication, November 26, 2012; 10.1038/onc.2012.539 Abstract | Full Text Androgen receptor degradation by the E3 ligase CHIP modulates mitotic arrest in prostate cancer cells S Sarkar, D L Brautigan, S J Parsons and J M Larner Oncogene 2014 33: 26-33; advance online publication, December 17, 2012; 10.1038/onc.2012.561 Abstract | Full Text Cbl-independent degradation of Met: ways to avoid agonism of bivalent Met-targeting antibody J M Lee, B Kim, S B Lee, Y Jeong, Y M Oh, Y-J Song, S Jung, J Choi, S Lee, K H Cheong, D U Kim, H W Park, Y K Han, G W Kim, H Choi, P H Song and K A Kim Oncogene 2014 33: 34-43; advance online publication, December 3, 2012; 10.1038/onc.2012.551 Abstract | Full Text BCR-ABL/GATA1/miR-138 mini circuitry contributes to the leukemogenesis of chronic myeloid leukemia C Xu, H Fu, L Gao, L Wang, W Wang, J Li, Y Li, L Dou, X Gao, X Luo, Y Jing, C-S Chim, X Zheng and L Yu Oncogene 2014 33: 44-54; advance online publication, December 3, 2012; 10.1038/onc.2012.557 Abstract | Full Text Antiproliferative protein Tob directly regulates c-myc proto-oncogene expression through cytoplasmic polyadenylation element-binding protein CPEB K Ogami, N Hosoda, Y Funakoshi and S Hoshino Oncogene 2014 33: 55-64; advance online publication, November 26, 2012; 10.1038/onc.2012.548 Abstract | Full Text MEK1–RSK2 contributes to hedgehog signaling by stabilizing GLI2 transcription factor and inhibiting ubiquitination Z Liu, T Li, M I Reinhold and M C Naski Oncogene 2014 33: 65-73; advance online publication, December 3, 2012; 10.1038/onc.2012.544 Abstract | Full Text Enhancement of leptin receptor signaling by SOCS3 deficiency induces development of gastric tumors in mice K Inagaki-Ohara, H Mayuzumi, S Kato, Y Minokoshi, T Otsubo, Y I Kawamura, T Dohi, G Matsuzaki and A Yoshimura Oncogene 2014 33: 74-84; advance online publication, November 26, 2012; 10.1038/onc.2012.540 Abstract | Full Text The role of insulin-like growth factor binding protein-3 in the breast cancer cell response to DNA-damaging agents M Z Lin, K A Marzec, J L Martin and R C Baxter Oncogene 2014 33: 85-96; advance online publication, November 26, 2012; 10.1038/onc.2012.538 Abstract | Full Text Interaction with colon cancer cells hyperactivates TGF-β signaling in cancer-associated fibroblasts L J A C Hawinkels, M Paauwe, H W Verspaget, E Wiercinska, J M van der Zon, K van der Ploeg, P J Koelink, J H N Lindeman, W Mesker, P ten Dijke and C F M Sier Oncogene 2014 33: 97-107; advance online publication, December 3, 2012; 10.1038/onc.2012.536 Abstract | Full Text CHK2 kinase promotes pre-mRNA splicing via phosphorylating CDK11p110 H-H Choi, H-K Choi, S Y Jung, J Hyle, B-J Kim, K Yoon, E-J Cho, H-D Youn, J M Lahti, J Qin and S-T Kim Oncogene 2014 33: 108-115; advance online publication, November 26, 2012; 10.1038/onc.2012.535 Abstract | Full Text Generation of cancer stem-like cells through the formation of polyploid giant cancer cells S Zhang, I Mercado-Uribe, Z Xing, B Sun, J Kuang and J Liu Oncogene 2014 33: 116-128; advance online publication, March 25, 2013; 10.1038/onc.2013.96 Abstract | Full Text Short Communication Top ATM deficiency augments constitutively nuclear cyclin D1-driven genomic instability and lymphomagenesis L P Vaites, Z Lian, E K Lee, B Yin, A DeMicco, C H Bassing and J A Diehl Oncogene 2014 33: 129-133; advance online publication, January 14, 2013; 10.1038/onc.2012.577 Abstract | Full Text Corrigendum Top Generation of cancer stem-like cells through the formation of polyploid giant cancer cells S Zhang, I Mercado-Uribe, Z Xing, B Sun, J Kuang and J Liu Oncogene 2014 33: 134; 10.1038/onc.2013.318 Full Text Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2014 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.